Printer Friendly

Articles from M2 Pharma (August 2, 2011)

1-8 out of 8 article(s)
Title Author Type Words
Actelion Phase IIb study meets primary endpoint with S1P1 receptor agonist ponesimod. 245
Biotest divests microbiological monitoring unit to German Merck. 119
Fresenius raises 2011 profit forecast on H1 figures. Financial report 186
Jennerex announces publication of proof-of-concept trial data on JX-594 in metastatic melanoma. 231
Joseph Scodari resigns from Actelion's board of directors. 124
Nordea upgrades rating on Active Biotech to "hold". 121
Siemens acquires insolvent HearUSA for USD129m. 155
Swedish Orphan Biovitrum announces patient enrollment in Phase III trial with Kiobrina. Clinical report 173

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters